Jefferies Group's ABVX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 10,153 shares of ABIVAX Société Anonyme (ABVX) worth $1.13 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in ABVX for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q1 2026, reducing 447,172 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's ABIVAX Société Anonyme (ABVX) Holding Value Over Time
Track share changes against reported price movement
Quarterly ABIVAX Société Anonyme (ABVX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -447,172 | Reduce 97.78% | 10,153 | $111.35 |
| Q3 2025 | +457,325 | New Buy | 457,325 | $84.90 |
Jefferies Group's ABIVAX Société Anonyme Investment FAQs
Jefferies Group first purchased ABIVAX Société Anonyme (ABVX) in Q3 2025, acquiring 457,325 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held ABIVAX Société Anonyme (ABVX) for 3 quarters since Q3 2025.
Jefferies Group's largest addition to ABIVAX Société Anonyme (ABVX) was in Q3 2025, adding 457,325 shares worth $38.83 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 10,153 shares of ABIVAX Société Anonyme (ABVX), valued at approximately $1.13 M.
As of the Q1 2026 filing, ABIVAX Société Anonyme (ABVX) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in ABIVAX Société Anonyme (ABVX) was 457,325 shares, as reported at the end of Q3 2025.